ストックスクリーナーアプリを入手
12.46
0.48%
0.06
アフターアワーズ：
12.46
Viatris Inc (VTRS) 最新ニュース
Viatris Inc.: How a Quiet Generic Drug Giant Is Re?wiring Global Healthcare - AD HOC NEWS
Is Viatris stock outperforming the Dow? - MSN
Viatris (VTRS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Taxanes Market to Reach US$ 8.67 Billion by 2032 at 10.73% CAGR; - openPR.com
1 Healthcare Stock to Target This Week and 2 We Turn Down - FinancialContent
Anti-Depression Drugs Market to Reach USD 22.10 Billion by 2031 | - openPR.com
Viatris Inc.: Can a Hybrid Pharma Powerhouse Redefine Global Generics and Biosimilars? - AD HOC NEWS
Take Profit: Will Viatris Inc stock outperform Nasdaq indexJuly 2025 Setups & Verified Chart Pattern Signals - moha.gov.vn
Viatris Inc. (VTRS) Provides Updates on Four Recent Regulatory Milestones - Finviz
Viatris Inc (VTRS)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus
Viatris stock hits 52-week high at $12.60 By Investing.com - Investing.com Nigeria
Viatris stock hits 52-week high at $12.60 - Investing.com India
Viatris Inc. stock rises Wednesday, outperforms market - MSN
Barclays Initiates Viatris (VTRS) with Overweight as Pharma Sentiment Improves - Insider Monkey
Viatris Inc. stock rises Tuesday, outperforms market - MarketWatch
Viatris Earnings Notes - Trefis
Viatris Inc. (VTRS) Stock Analysis: Navigating a 3.90% Dividend Yield Amidst Challenging Metrics - DirectorsTalk Interviews
Viatris Inc. Stock Climbs 1.8%, Outperforms Market - 富途牛牛
Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025 - FinancialContent
How Is The Market Feeling About Viatris Inc?Viatris (NASDAQ:VTRS) - Benzinga
Viatris: Looks Cheap, But Faces Continued Contraction (NASDAQ:VTRS) - Seeking Alpha
Wall Street Recap: How strong is Viatris Inc. stock revenue growthStock Surge & Safe Capital Growth Trade Ideas - moha.gov.vn
Why Viatris Inc. stock remains on buy listsWeekly Gains Summary & Safe Entry Momentum Stock Tips - Bölüm Sonu Canavarı
Earnings Risk: How Viatris Inc. (VIA) stock trades after earningsPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - ulpravda.ru
Is Viatris’ Shift Into Complex Therapies Altering The Investment Case For VTRS? - Yahoo Finance
Viatris (VTRS): Reassessing Valuation After Recent Share Price Gains and Evolving Investor Sentiment - Yahoo Finance
Opus Genetics Partner Files Supplemental NDA for Presbyopia Drug - TipRanks
Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates - Yahoo News Malaysia
Is Viatris Inc. stock safe for conservative investorsEarnings Miss & Fast Moving Stock Watchlists - DonanımHaber
Viatris’ MR-146 gains IND clearance for neurotrophic keratopathy - BioWorld MedTech
Viatris secures four regulatory milestones across global pipeline By Investing.com - Investing.com Australia
Will Viatris Inc. stock outperform Nasdaq index2025 Valuation Update & Verified Technical Trade Signals - DonanımHaber
Viatris Provides Pipeline Update on Four Regulatory Milestones - The Malaysian Reserve
Update Recap: How Viatris Inc. stock valuations compare to rivalsWeekly Market Report & Fast Entry Momentum Alerts - Улправда
Chemotherapy Induced Anemia Market Intelligence Report 2025-2032, Featuring Amgen, Johnson & Johnson - PharmiWeb.com
Viatris racks up regulatory wins across therapy areas - The Pharma Letter
Viatris Says FDA Approves Octreotide Acetate, Clears MR-146 for Clinical Trials - marketscreener.com
Rally Mode: How Viatris Inc VIA stock behaves in tightening cyclesQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - moha.gov.vn
Viatris secures four regulatory milestones across global pipeline - Investing.com
Viatris provides pipeline update on four regulatory milestones - marketscreener.com
Viatris Provides Pipeline Update On Four Regulatory Milestones - TradingView — Track All Markets
Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Malaysian Reserve
Viatris to Present at the 44th Annual J.P. Morgan Healthcare Con - GuruFocus
Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch
Does Viatris’ Reshaping Strategy Make Sense After Recent Share Price Swings? - Yahoo Finance
Viatris Recognized as 2025 Best Workplaces™ in Ontario and for Giving Back - The Globe and Mail
2.38%
1.30%
大文字化:
|
ボリューム (24 時間):